I'm LongbridgeAI, I can summarize articles.Major healthcare insurers UNH, Humana, and CVS are surging due to a 2.48% Medicare Advantage payment hike by the Trump administration. This policy shift prompted companies to raise earnings forecasts and attracted Wall Street analysts who upgraded price targets. Valuations remain attractive, with upcoming earnings reports serving as key catalysts for future performance.
Top health insurance stocks are soaring this year and are beating popular technology names like Nvidia (NASDAQ:NVDA) and Palantir (NASDAQ:PLTR).
UnitedHealth Group (NYSE:UNH) has jumped by over 65% from its lowest point this year, while Humana (NYSE:HUM) is up by 142%. CVS Health (NYSE:CVS) rose to $104, up by 50% from the year-to-date low.
UNH, CVS, and HUM stocks chart | Source: TradingView
The rally is a major reversal considering that these companies have been some of the top laggards in Wall Street in the past few years. The situation at UnitedHealth escalated last year when it plunged from $595 to $250 within a few weeks. In the aftermath, the company suspended its 2025 outlook and replaced Andrew Witty as Chairman with Stephen Hemsley.
The ongoing rally in healthcare insurance companies is likely because the Donald Trump administration increased the payments to insurers under the Medicare Advantage plans. It hiked the payments by 2.48%, equivalent to $13 billion, higher than the proposed 0.09%.
Read Also: MSTR Stock Stages Relief Rally as Peter Schiff Calls Out Michael Saylor
As a result, most of these companies boosted their forward outlook for the year. UnitedHealth Group said that its adjusted earnings per share will be $18.25 this year, higher than the previous $17.75.
Similarly, CVS, which runs the biggest pharmacy chain, and Aetna, hiked its full-year profit to between $7.30 and $7.50 from the previous range of between $7 and $7.20. Humana and Elevance Health (NYSE:ELV) also boosted their outlooks.
Top Wall Street analysts are taking note of the new developments and boosting their outlooks for health insurance companies. Morgan Stanley recently boosted its UNH stock forecast from $453 to $468, while Bank of America and Leerink Partners hiked to $475 and $462, respectively.
Similarly, Bank of America, Mizuho, and Morgan Stanley boosted their CVS stock outlook to over $110, up slightly from the current $104. Bank of America, Evercore, and Mizuho also hiked Humana’s forecasts.
These upgrades happened as their valuations remains attractive. Humana trades at a forward price-to-earnings ratio of 14, while CVS and UnitedHealth Group have 14.10 and 22, respectively.
Looking ahead, the next key catalysts for these stocks will be their earnings, which will shed light on their performance. UnitedHealth will publish its numbers on July 16, while CVS and Humana will release their numbers on August 5 and July 29, respectively.
Read Also: Bitcoin Price Attempts Recovery as ETF Outflows Suggest Rotation to Stocks
Image: Shutterstock